172 related articles for article (PubMed ID: 25535398)
1. INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study.
Giordano FA; Brehmer S; Abo-Madyan Y; Welzel G; Sperk E; Keller A; Schneider F; Clausen S; Herskind C; Schmiedek P; Wenz F
BMC Cancer; 2014 Dec; 14():992. PubMed ID: 25535398
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial.
Giordano FA; Brehmer S; Mürle B; Welzel G; Sperk E; Keller A; Abo-Madyan Y; Scherzinger E; Clausen S; Schneider F; Herskind C; Glas M; Seiz-Rosenhagen M; Groden C; Hänggi D; Schmiedek P; Emami B; Souhami L; Petrecca K; Wenz F
Neurosurgery; 2019 Jan; 84(1):41-49. PubMed ID: 29528443
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal MRI findings in patients with newly diagnosed glioblastoma after intraoperative radiotherapy.
Förster A; Böhme J; Maros ME; Brehmer S; Seiz-Rosenhagen M; Hänggi D; Wenz F; Groden C; Pope WB; Giordano FA
J Neuroradiol; 2020 Mar; 47(2):166-173. PubMed ID: 30659892
[TBL] [Abstract][Full Text] [Related]
4. Study Protocol: Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma (Gamma-GBM).
Brehmer S; Grimm MA; Förster A; Seiz-Rosenhagen M; Welzel G; Stieler F; Wenz F; Groden C; Mai S; Hänggi D; Giordano FA
Neurosurgery; 2019 May; 84(5):1133-1137. PubMed ID: 29688510
[TBL] [Abstract][Full Text] [Related]
5. [Intraoperative radiotherapy (IORT) in malignant brain tumors].
Wagner W; Schüller P; Willich N; Schober O; Palkovic S; Morgenroth C; Bartenstein P; Prott FJ; Niewöhner U
Strahlenther Onkol; 1995 Mar; 171(3):154-64. PubMed ID: 7709332
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of external beam-radiotherapy combined with daily administration of low-dose cisplatin for supratentorial glioblastoma multiforme--a pilot study.
Shinoda J; Sakai N; Hara A; Ueda T; Sakai H; Nakatani K
J Neurooncol; 1997 Oct; 35(1):73-80. PubMed ID: 9266443
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experiences with intraoperative radiation therapy (IORT) for the treatment of brain tumors.
Chung YG; Kim CY; Lee HK; Lee KC; Chu JW; Choi MS
J Korean Med Sci; 1995 Dec; 10(6):449-52. PubMed ID: 8924231
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
10. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
[TBL] [Abstract][Full Text] [Related]
11. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
12. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
[TBL] [Abstract][Full Text] [Related]
15. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Dosimetry Formalisms in Intraoperative Radiation Therapy of Glioblastoma.
Ayala Alvarez DS; Watson PGF; Popovic M; Heng VJ; Evans MDC; Panet-Raymond V; Seuntjens J
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):763-773. PubMed ID: 37150259
[TBL] [Abstract][Full Text] [Related]
17. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
[TBL] [Abstract][Full Text] [Related]
18. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
20. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]